- Home
- About Us
- Products
- Our Capabilities
- Services
- Contract Development and Manufacturing Organisation {CDMO)
- Contract Manufacturing (CMO]
- Contract Research (CRO)
- Custom Synthesis / Third— Party Manufacturing
- DMF Preparation
- Formulation Research & Development (FR&D)
- Global Marketing Representation
- Market Research & Business Intelligence
- Quality Control (QC) Auditing
- Strategic Marketing
- Supply Chain Management
- Technology Transfer & Scale Up
- Business Partners
- Contact Us
Ranitidine Hydrochloride Tablets IP 150 mg
CATEGORY : Anti-Ulcer
Ranitidine Pellets
USAGE : Anti Ulcerative
TYPE : Sustained Release /Controlled Release /Timed Release Pellets
Ranitidine Tablets IP 300 mg
CATEGORY : Anti-Ulcer
Ranolazine
CAS NO : 95635-55-5
THERAPEUTIC CATEGORY : Cardiovascular/Antihypertensive
Rasagiline Mesylate
CAS NO : 161735-79-1
THERAPEUTIC CATEGORY : Antiparkinsonian
Rasagiline Tartarate
CAS NO : 136236-52-7
THERAPEUTIC CATEGORY : Neuropsychiatry/Antiparkinsonian
Rebamipide
CAS NO : 90098-04-07
THERAPEUTIC CATEGORY : Antiulceratives
Regorafenib Form I
CAS NO : 755037-03-7
THERAPEUTIC CATEGORY : Anti Cancer
rel-(3aR,12bR)-5-Chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrole 2-oxide
API : Asenapine
CAS NO : 1367373-77-0
IMPURUTY NAME : Asenapine Maleate N-Oxide Impurity
Repaglinide
CAS NO : 135062-02-1
THERAPEUTIC CATEGORY : Anti-Diabetic
Residronate Sodium
CAS NO : 115436-72-1
THERAPEUTIC CATEGORY : Antiosteoporosis
Retigabine
CAS NO : 150812-12-7
THERAPEUTIC CATEGORY : Anticonvulsants/Antiepileptics
Ribavirin
CAS NO : 36791-04-05
THERAPEUTIC CATEGORY : Anti Viral
RibociclibPALCOCICLIB
CAS NO : 1211441-98-3
THERAPEUTIC CATEGORY : Anti Cancer
Riboflavine Pellets
USAGE : Nutraceutical Pellets
TYPE : Immediate Release / Uncoated Pellets